Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patientsChristina Rautenberg, Friedrich Stölzel, Matthias Stelljes et al.|Blood Cancer Journal|2025Cited by 6
VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AMLChristoph Röllig, Leo Ruhnke, Christoph Schliemann et al.|Annals of Hematology|2025Cited by 4